Literature DB >> 30615368

[2014 International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma].

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 30615368

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN： 0047-1852


× No keyword cloud information.
  5 in total

1.  Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.

Authors:  Wei Wang; Yinghua Xie; Xiyao Han; Yihan Liu; Pei Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

2.  Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.

Authors:  Virginie Royal; Nelson Leung; Stéphan Troyanov; Samih H Nasr; Laure Écotière; Richard LeBlanc; Benjamin A Adam; Andrea Angioi; Mariam P Alexander; Anna Maria Asunis; Antonella Barreca; Paola Bianco; Camille Cohen; Maria E Drosou; Huma Fatima; Roberta Fenoglio; François Gougeon; Jean-Michel Goujon; Guillermo A Herrera; Bertrand Knebelmann; Nicola Lepori; Francesca Maletta; Rita Manso; Shveta S Motwani; Antonello Pani; Marion Rabant; Helmut G Rennke; Dario Rocatello; Frida Rosenblum; Paul W Sanders; Afonso Santos; Karina Soto; Banu Sis; Guy Touchard; Christopher P Venner; Frank Bridoux
Journal:  Blood       Date:  2020-05-21       Impact factor: 25.476

3.  Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma.

Authors:  Ala Abudayyeh; Heather Lin; Omar Mamlouk; Maen Abdelrahim; Rima Saliba; Gabriela Rondon; Charles S Martinez; Ruby Delgado; Valda Page; Arun Rajasekaran; Paul W Sanders; Muzaffar Qazilbash
Journal:  Leuk Lymphoma       Date:  2020-07-29

4.  Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.

Authors:  Cui Zhang; Min Chu; Yingchao Fan; Liting Wu; Zhumeng Li; Xiaoyan Ma; Wenfang Zhuang
Journal:  J Clin Lab Anal       Date:  2020-06-23       Impact factor: 2.352

5.  Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.

Authors:  Xuesong Li; Ying Yang; Xue Yi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.